(Q38058244)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23132321%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

title

Pathophysiology of prediabetes and treatment implications for the prevention of type 2 diabetes mellitus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23132321%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

0 references

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23132321%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

author name string

Michael Bergman

series ordinal

1

1 reference

27 August 2017

publication date

7 November 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23132321%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23132321%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23132321%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23132321%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

page(s)

504-513

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23132321%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s12020-012-9830-9

17 February 2020

exact match

0 references

cites work

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9830-9

Follow-up report on the diagnosis of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9830-9

Standards of medical care in diabetes--2012

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9830-9

International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9830-9

Preservation of β-cell function: the key to diabetes prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9830-9

Global estimates of the prevalence of diabetes for 2010 and 2030

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9830-9

Prediabetes: a high-risk state for diabetes development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9830-9

Prevention of diabetes and reduction in major cardiovascular events in studies of subjects with prediabetes: meta-analysis of randomised controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9830-9

Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9830-9

Normal fasting plasma glucose levels and type 2 diabetes in young men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9830-9

Inadequacies of absolute threshold levels for diagnosing prediabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9830-9

Plasma glucose levels as predictors of diabetes: the Mexico City diabetes study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9830-9

Screening for pre-diabetes to predict future diabetes using various cut-off points for HbA(1c) and impaired fasting glucose: the Toranomon Hospital Health Management Center Study 4 (TOPICS 4).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9830-9

Hemoglobin A1c versus oral glucose tolerance test in postpartum diabetes screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9830-9

The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9830-9

Five stages of evolving beta-cell dysfunction during progression to diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9830-9

Minimal contribution of fasting hyperglycemia to the incidence of type 2 diabetes in subjects with normal 2-h plasma glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9830-9

Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9830-9

Dynamics of insulin secretion and the clinical implications for obesity and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9830-9

Prediabetes: evaluation of β-cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9830-9

Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9830-9

What is the best predictor of future type 2 diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9830-9

One-hour plasma glucose concentration and the metabolic syndrome identify subjects at high risk for future type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9830-9

Fasting versus postload plasma glucose concentration and the risk for future type 2 diabetes: results from the Botnia Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9830-9

Free fatty acid-induced hepatic insulin resistance is attenuated following lifestyle intervention in obese individuals with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9830-9

Saturated free fatty acids: islet β cell "stressERs".

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9830-9

Prediabetes in obese youth: a syndrome of impaired glucose tolerance, severe insulin resistance, and altered myocellular and abdominal fat partitioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9830-9

Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9830-9

Mechanism of action of DPP-4 inhibitors--new insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9830-9

Mechanisms for the antihyperglycemic effect of sitagliptin in patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9830-9

Successful treatment of prediabetes in clinical practice: targeting insulin resistance and β-cell dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9830-9

Approach to the patient with prediabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9830-9

The prevention of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9830-9

Prediabetes: The Importance of Early Identification and Intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9830-9

Impaired fasting glucose and impaired glucose tolerance: implications for care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9830-9

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9830-9

Voglibose for prevention of type 2 diabetes mellitus: a randomised, double-blind trial in Japanese individuals with impaired glucose tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9830-9

Activation of sodium-glucose cotransporter 1 ameliorates hyperglycemia by mediating incretin secretion in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9830-9

Effect of nateglinide on the incidence of diabetes and cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9830-9

Basal insulin and cardiovascular and other outcomes in dysglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9830-9

Treatment of prehypertension in diabetes and metabolic syndrome: what are the pros?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9830-9

Reduced cardiovascular morbidity and mortality in hypertensive diabetic patients on first-line therapy with an ACE inhibitor compared with a diuretic/beta-blocker-based treatment regimen: a subanalysis of the Captopril Prevention Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9830-9

Assessment and treatment of cardiovascular risk in prediabetes: impaired glucose tolerance and impaired fasting glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9830-9

Thiazide diuretics alone or with beta-blockers impair glucose metabolism in hypertensive patients with abdominal obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9830-9

Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9830-9

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9830-9

Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9830-9

Statins: Is It Really Time to Reassess Benefits and Risks?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9830-9

Elevated plasma glucose 2 h postchallenge predicts defects in beta-cell function

21 January 2018

1 reference

12 December 2020

Antihypertensive medications and the risk of incident type 2 diabetes

1 reference

12 December 2020

Brief, irregular oscillations of basal plasma insulin and glucose concentrations in diabetic man

1 reference

12 December 2020

Orchestration of glucose homeostasis: from a small acorn to the California oak

1 reference

12 December 2020